2016 BHIVA GUIDELINES for the treatment of HIV-1-positive Adults with antiretroviral therapy
The British HIV Association
Laura Waters (Chair)
N Ahmed, B Angus, M Boffito, M Bower, D Churchill, D Dunn, S Edwards, C Emerson, S Fidler, †M Fisher, R Horne, S Khoo, C Leen, N Mackie, N Marshall, F Monteiro, M Nelson, C Orkin, A Palfreeman, S Pett, A Phillips, F Post, A Pozniak, I Reeves, C Sabin, R Trevelion, J Walsh, E Wilkins, I Williams, A Winston
†Professor Martin Fisher died in April 2015 – he made a significant contribution to these, many other guidelines and our speciality as a whole – he is greatly missed.
The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of adults with HIV infection on antiretroviral therapy (ART).
The scope includes: (i) guidance on the initiation of ART in those previously naïve to therapy; (ii) support of people living with HIV (PLWH) on treatment; (iii) management of individuals experiencing virological failure; and (iv) recommendations in specific populations where other factors need to be taken into consideration.
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA guidelines.
The 2016 interim update to the 2015 BHIVA antiretroviral guidelines has been published online to include tenofovir-alafenamide/emtricitabine as a preferred NRTI backbone for first-line therapy. Changes were based on new data and the consensus opinion of the writing committee. All changes to the guideline are highlighted and include updates to the chronic kidney disease and bone disease sections of special populations and some small changes to managing virological failure. The next formal update to the guidelines in anticipated in 2017.
Entry filed under: Antirretrovirales, CONSENSOS, GUIDELINES, HIV/SDA en Seniles, HIV/SIDA, HIV/SIDA Co-infeccion HBV, HIV/SIDA Co-infeccion HCV, HIV/SIDA Co-Infeccion HEV, HIV/SIDA Complicaciones, HIV/SIDA Controladores de elite, HIV/SIDA HAART, HIV/SIDA HSH, HIV/SIDA Infeccion Aguda / Reciente, HIV/SIDA Infecciones Oportunistas, HIV/SIDA Laboratorio, HIV/SIDA Lipodistrofia, HIV/SIDA Mujeres, HIV/SIDA Prevencion, HIV/SIDA Trastornos Cardíacos, HIV/SIDA Trastornos GI, HIV/SIDA Trastornos Hemato-Oncológicos, HIV/SIDA Trastornos hepaticos, HIV/SIDA Trastornos Neurológicos, HIV/SIDA Trastornos Oculares, HIV/SIDA Trastornos Oseos, HIV/SIDA Trastornos Piel y Tej Blandos, HIV/SIDA Trastornos renales, HIV/SIDA Trastornos respiratorias.